GEN-MKT-18-7897-A
Feb 1, 2022 | Blogs, Cannabis, Food / Beverage, Food and Beverage | 0 comments
Read time: 2 minutes
As the new year commences and we make plans for 2022, cannabis will be a hot topic in some areas of the world. There may be continuations from 2021 around legislations and regulations, and we might even see new trends for some regions and countries.
Legalization of recreational cannabis in Germany
Let’s first discuss the news that is at the top of my list: legalization of cannabis for recreational use in Germany. In December 2021, Germany welcomed a new chancellor, Olaf Scholz, who has several plans on his agenda, including legalizing cannabis.1 Currently, it is not illegal to consume cannabis, but it is to buy it. This would make Germany the first major European country to legalize recreational marijuana.2
The parties in the new coalition government agreed to legalize the sale of cannabis to adults if it is sold in licensed establishments where it is properly taxed and quality controlled. Some believe this move will allow Germany to “have a regulated and taxed dispensary, controllable quality and effective youth protection through education.”2 However, some of the other parties are not in favor of this. For example, Markus Blume, the party secretary of the CSU, believes it will make a “harmful” drug into a “lifestyle product,” and according to a study, 59% of people say it would be better left the way it has been since 2011.2
Although we can’t say for certain that Olaf Scholz will implement this decision, it will be a hot topic in this year’s cannabis news, so watch for updates.
Cannabis in the US
For most of human history, until the early 20th century, cannabis use was legal in the US. Between 1916 and 1931, however, 29 US states banned the use of marijuana.3 Then came the Marihuana Tax Act of 1937, which was influenced by the Federal Bureau of Narcotics Commissioner at the time, Harry Anslinger and essentially made cannabis illegal across the US.4
When we look at the legislation in place today, we can see the legalization of cannabis has started to come full circle across the US. As of July 2021, cannabis had been legalized for recreational use in 18 states and approved for medical use in 37 states.5 Given this groundswell of support for medical and recreational cannabis use, might 2022 bring a federal move to legalization? Let’s take a look.
Back in September 2021, a key committee in the US House of Representatives approved a bill to federally legalize marijuana with an aim of promoting social equity.6 While federal cannabis legalization does not appear to be a priority for the Biden administration, efforts continue in the House and the US Senate to bring federal policy closer in line with state laws. With these efforts ongoing, and with 60% of adults believing that cannabis should be legal for both medical and recreational use 7, might 2022 be the year we see federal legalization?
References
RUO-MKT-18-14262-A
Regulated laboratories are evolving faster than ever. New analytical modalities, higher sample throughput, increasing regulatory scrutiny, and leaner teams are reshaping how work gets done. At the same time, expectations for data integrity, standardization, and operational efficiency continue to increase complexity and/or scope. In this environment, LC-MS software is no longer simply an instrument control platform—it has become a critical part of a laboratory’s quality management system. The question is no longer whether your lab has changed, but whether your software has evolved to support the way regulated labs operate today, and if they are ready and able to meet the demands, they will face tomorrow.
Analyst software has long been a trusted foundation in regulated LC-MS laboratories—and for many, it still performs reliably today. But regulated environments are evolving faster than ever. As labs transition to Windows 11, strengthen cybersecurity policies, modernize IT infrastructure, and prepare for future compliance expectations, software decisions are no longer just about what works today—they’re about managing tomorrow’s risk. Analyst will not be supported on Windows 11. While some labs may continue operating in unsupported environments temporarily, the bigger question is: when that risk becomes reality, will your lab be reacting under pressure—or executing a planned mitigation strategy with confidence?
As regulatory scrutiny increases and detection requirements tighten, laboratories are facing a new question: How can TFA be measured reliably, sensitively, and at scale?
Posted by
You must be logged in to post a comment.
Share this post with your network